Skip to main content
SpringerLink
Log in

Status Epilepticus

  • Chapter
  • First Online:
Pediatric Critical Care Medicine

  • 2790 Accesses

Abstract

The critically ill child with ongoing seizures refractory to treatment presents a challenge in neurocritical care. This chapter reviews the recent literature on refractory and super-refractory status epilepticus and summarizes the strategy regarding second-tier anti-epileptic drug therapies that can be used once initial anticonvulsants have failed. The pediatric experience of high-dose midazolam, barbiturate anesthesia, volatile anesthetics, hypothermia, ketamine and ketogenic diet for uncontrolled status epilepticus is summarized and evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tasker RC. Emergency treatment of acute seizures and status epilepticus. Arch Dis Child. 1998;79:78–83.

    CAS  PubMed Central  PubMed  Google Scholar 

  2. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–35.

    CAS  PubMed  Google Scholar 

  3. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997;38:1344–9.

    CAS  PubMed  Google Scholar 

  4. Waterhouse EJ, Garnett LK, Towne AR, et al. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia. 1999;40:752–8.

    CAS  PubMed  Google Scholar 

  5. Raspall-Chaure M, Chin RF, Neville BG, Scott RC. Outcome of paediatric convulsive status epilepticus: a systematic review. Lancet Neurol. 2006;5:769–79.

    PubMed  Google Scholar 

  6. Chin RFM, Neville BGR, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368:222–9.

    PubMed  Google Scholar 

  7. Pujar SS, Neville BG, Scott RC, Chin RF, North London Epilepsy Research Network. Death within 8 years after childhood convulsive status epilepticus: a population-based study. Brain. 2011;134:2819–27.

    PubMed Central  PubMed  Google Scholar 

  8. Loddenkemper T, Syed TU, Ramgopal S, et al. Risk factors associated with death in in-hospital pediatric convulsive status epilepticus. PLoS One. 2012;7:e47474.

    CAS  PubMed Central  PubMed  Google Scholar 

  9. Barnard C, Wirrell E. Does status epilepticus in children cause developmental deterioration and exacerbation of epilepsy? J Child Neurol. 1999;14:787–94.

    CAS  PubMed  Google Scholar 

  10. Chin RFM, Neville BGR, Peckham C, et al. Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol. 2008;7:696–703.

    CAS  PubMed Central  PubMed  Google Scholar 

  11. Sahin M, Menache CC, Holmes GL, Riviello JJ. Outcome of severe refractory status epilepticus in children. Epilepsia. 2001;42:1461–7.

    CAS  PubMed  Google Scholar 

  12. Novorol CL, Chin RF, Scott RC. Outcome of convulsive status epilepticus: a review. Arch Dis Child. 2007;92:948–51.

    PubMed Central  PubMed  Google Scholar 

  13. Babl FE, Sheriff N, Borland M, et al. Emergency management of paediatric status epilepticus in Australia and New Zealand: practice patterns in the context of clinical practice guidelines. J Paediatr Child Health. 2009;45:541–6.

    PubMed  Google Scholar 

  14. Shearer P, Riviello J. Generalized convulsive status epilepticus in adults and children: treatment guidelines and protocols. Emerg Med Clin N Am. 2011;29:51–64.

    Google Scholar 

  15. Meldrum BS, Horton RW. Physiology of status epilepticus in primates. Arch Neurol. 1973;28:1–9.

    CAS  PubMed  Google Scholar 

  16. Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates. Arch Neurol. 1973;28:10–7.

    CAS  PubMed  Google Scholar 

  17. Meldrum BS, Vigouroux RA, Brierley JB. Systemic factors and epileptic brain damage: prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol. 1973;29:82–7.

    CAS  PubMed  Google Scholar 

  18. Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology. 1990;40 Suppl 2:13–23.

    CAS  PubMed  Google Scholar 

  19. Freeman JM. Status epilepticus: it’s not what we’ve thought or taught. Pediatrics. 1989;83:444–5.

    CAS  PubMed  Google Scholar 

  20. Chin RF, Verhulst L, Neville BG, Peters MJ, Scott RC. Inappropriate emergency management of status epilepticus in children contributes to need for intensive care. J Neurol Neurosurg Psychiatry. 2004;75:1584–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  21. Tobias JD, Berenbosch JW. Management of status epilepticus in infants and children prior to pediatric ICU admission: deviations from the current guidelines. South Med J. 2008;101:268–72.

    PubMed  Google Scholar 

  22. Wilkes R, Tasker RC. Pediatric intensive care treatment of uncontrolled status epilepticus. Crit Care Clin. 2013;29:239–57.

    PubMed  Google Scholar 

  23. Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia. 1993;34:592–6.

    Google Scholar 

  24. Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40:120–2.

    CAS  PubMed  Google Scholar 

  25. Shinnar S, Berg AT, Moshe SL, et al. How long do new-onset seizures in children last? Ann Neurol. 2001;49:659–64.

    CAS  PubMed  Google Scholar 

  26. Kramer R, Levisohn P. The duration of secondarily generalized tonic-clonic seizures (abstract). Epilepsia. 1992;33:68.

    Google Scholar 

  27. Theodore W, Porter R, Albert P, et al. The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology. 1994;44:1403–7.

    CAS  PubMed  Google Scholar 

  28. Lahat E, Goldman M, Barr J, et al. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomized study. BMJ. 2000;321:83–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  29. Smith RA, Martland T, Lowry MF. Children with seizures presenting to accident and emergency. J Accid Emerg Med. 1996;13:54–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  30. Wasterlain CG, Chen JW. Definition and classification of status epilepticus. In: Wasterlain CG, Treiman DM, editors. Status epilepticus: mechanisms and management. Cambridge, MA: The MIT Press; 2006. p. 11–6.

    Google Scholar 

  31. Dieckmann RA. Is the time overdue for an international reporting standard for convulsive paediatric status epilepticus? Emerg Med Australas. 2006;18:1–3.

    PubMed  Google Scholar 

  32. Glauser TA. Designing practical evidence-based treatment plans for children with prolonged seizures and status epilepticus. J Child Neurol. 2007;22(5 Suppl):38S–46.

    PubMed  Google Scholar 

  33. Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia. 2006;47:1499–503.

    PubMed  Google Scholar 

  34. Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59:205–10.

    PubMed  Google Scholar 

  35. Walton NY, Treiman DM. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp Neurol. 1988;101:267–75.

    CAS  PubMed  Google Scholar 

  36. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. 1990;5:49–60.

    CAS  PubMed  Google Scholar 

  37. Wang NC, Good LB, Marsh ST, et al. EEG stages predict treatment response in experimental status epilepticus. Epilepsia. 2009;50:949–52.

    CAS  PubMed  Google Scholar 

  38. Koul R, Chacko A, Javed H, et al. Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome. J Child Neurol. 2002;17:908–10.

    PubMed  Google Scholar 

  39. Lambrechtsen FA, Buchhalter JR. Aborted and refractory status epilepticus in children: a comparative analysis. Epilepsia. 2008;49:615–25.

    PubMed  Google Scholar 

  40. Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia. 2011;52 Suppl 8:53–6.

    CAS  PubMed  Google Scholar 

  41. Wilder-Smith EP, Lim EC, Teoh HL, et al. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore. 2005;34:417–20.

    CAS  PubMed  Google Scholar 

  42. Van Baalen A, Stephani U, Kluger G, et al. FIRES: febrile infection responsive epileptic (FIRE) encephalopathies of school age. Brain Dev. 2009;31:92–3.

    Google Scholar 

  43. Chauvel P, Dravet C. The HHE syndrome. In: Roger J, Bureau M, Dravet C, et al., editors. Epileptic syndromes in infancy, childhood and adolescence. 4th ed. London: J Libbey; 2005. p. 277–93.

    Google Scholar 

  44. Nabbout R, Vezzani A, Dulac O, et al. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol. 2011;10:99–108.

    PubMed  Google Scholar 

  45. Ismail FY, Kossoff EH. AERRPS, DESC, NORSE, FIRES: multi-labeling or distinct epileptic entities? Epilepsia. 2011;52:e185–9.

    PubMed  Google Scholar 

  46. Brevoord JC, Joosten KF, Arts WF, et al. Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin. J Child Neurol. 2005;20:476–81.

    PubMed  Google Scholar 

  47. Sreenath TG, Gupta P, Sharma KK, et al. Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial. Eur J Paediatr Neurol. 2010;14:162–8.

    CAS  PubMed  Google Scholar 

  48. Walton NY, Treiman DM. Phenobarbital treatment of status epilepticus in a rodent model. Epilepsy Res. 1989;4:216–21.

    CAS  PubMed  Google Scholar 

  49. Abend NS, Marsh E. Convulsive and nonconvulsive status epilepticus in children. Curr Treat Options Neurol. 2009;11:262–72.

    PubMed  Google Scholar 

  50. Crawford TO, Mitchell WG, Fishman LS, et al. Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology. 1988;38:1035–40.

    CAS  PubMed  Google Scholar 

  51. Brigo F, Storti M, Del Felice A, Fiaschi A, Bongiovanni LG. IV valproate in generalized convulsive status epilepticus. Eur J Neurol. 2012;19:1180–91.

    CAS  PubMed  Google Scholar 

  52. Rogawski MA, Losher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004;5:553–64.

    CAS  PubMed  Google Scholar 

  53. Wheless JW, Clarke D, Hovinga CA, et al. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study. J Child Neurol. 2009;24:946–51.

    PubMed  Google Scholar 

  54. Abend NS, Monk HM, Licht DJ, Dlugos DJ. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures. Pediatr Crit Care Med. 2009;10:505–10.

    PubMed Central  PubMed  Google Scholar 

  55. Kirmani BF, Crisp ED, Kayani S, Rajab H. Role of intravenous levetiracetam in acute seizure management of children. Pediatr Neurol. 2009;41:37–9.

    PubMed  Google Scholar 

  56. Reiter PD, Huff AD, Knupp KG, Valuck RJ. Intravenous levetiracetam in the management of acute seizures in children. Pediatr Neurol. 2010;43:117–21.

    PubMed  Google Scholar 

  57. McTague A, Kneen R, Kumar R, Spinty S, Appleton R. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children’s hospital. Seizure. 2012;21:529–34.

    CAS  PubMed  Google Scholar 

  58. Tasker RC. Midazolam for refractory status epilepticus: higher dosing and more rapid and effective control. Intensive Care Med. 2006;32:1935–6.

    PubMed  Google Scholar 

  59. Federman MD, Kelly R, Harrison RE. Refractory metabolic acidosis as a complication of high-dose midazolam infusion for pediatric status epilepticus. Clin Neuropharmacol. 2009;32:340–1.

    PubMed  Google Scholar 

  60. Rivera R, Segnini M, Baltodano A, et al. Midazolam in the treatment of status epilepticus in children. Crit Care Med. 1993;21:991–4.

    CAS  PubMed  Google Scholar 

  61. Igartua J, Silver P, Maytal J, et al. Midazolam coma for refractory status epilepticus in children. Crit Care Med. 1999;27:1982–5.

    CAS  PubMed  Google Scholar 

  62. Singhi S, Murthy A, Singhi P, et al. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol. 2002;17:106–10.

    PubMed  Google Scholar 

  63. Koul RL, Raj Aithala G, Chacko A, et al. Continuous midazolam infusion as treatment of status epilepticus. Arch Dis Child. 1997;76:445–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  64. Ozdemir D, Gulez P, Uran N, et al. Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus. Seizure. 2005;14:129–32.

    PubMed  Google Scholar 

  65. Morrison G, Gibbons E, Whitehouse WP. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med. 2006;32:2070–6.

    CAS  PubMed  Google Scholar 

  66. Hayashi K, Osawa M, Aihara M, et al. Efficacy of intravenous midazolam for status epilepticus in childhood. Pediatr Neurol. 2007;36:366–72.

    PubMed  Google Scholar 

  67. Saz EU, Karapinar B, Ozcetin M, et al. Convulsive status epilepticus in children: etiology, treatment protocol, and outcome. Seizure. 2011;20:115–8.

    PubMed  Google Scholar 

  68. Tasker RC. Electroencephalographic seizure activity in the comatose critically ill child: getting closer to knowing what to do. Crit Care Med. 2013;41:362–3.

    PubMed  Google Scholar 

  69. US Food and Drug Administration: DIPRIVAN. Label approved on 04/14/2008 for DIPRIVAN, NDA No. 019627. www.accessdata.fda.gov/drugsatfda_docs/label/2008/019627s046lbl.pdf. Accessed 28 June 2013.

  70. Rossetti AO. Which anesthetic should be used in the treatment of refractory status epilepticus? Epilepsia. 2007;48 Suppl 8:52–5.

    PubMed  Google Scholar 

  71. Owens J. Medical management of refractory status epilepticus. Semin Pediatr Neurol. 2010;17:176–81.

    PubMed  Google Scholar 

  72. Stullken EH, Milde JH, Michenfelder JD, et al. The nonlinear responses of cerebral metabolism to low concentrations of halothane, enflurane, isoflurane, and thiopental. Anesthesiology. 1977;46:28–34.

    CAS  PubMed  Google Scholar 

  73. Barberio M, Reiter PD, Kaufman J, et al. Continuous infusion pentobarbital for refractory status epilepticus in children. J Child Neurol. 2012;27:721–6.

    PubMed  Google Scholar 

  74. Krishnamurthy KB, Drislane FW. Depth of EEG suppression and outcome in barbiturate anesthetic for refractory status epilepticus. Epilepsia. 1999;40:759–62.

    CAS  PubMed  Google Scholar 

  75. Schreiber JM, Gaillard WD. Treatment of refractory status epilepticus in childhood. Curr Neurol Neurosci Rep. 2011;11:195–204.

    PubMed  Google Scholar 

  76. Kim SJ, Lee DY, Kim JS. Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol. 2001;25:217–20.

    CAS  PubMed  Google Scholar 

  77. van Gestel JP, Blusse van Oud-Albias HJ, Malingre M. Propofol and thiopental for refractory status epilepticus in children. Neurology. 2005;65:591–2.

    PubMed  Google Scholar 

  78. Sakuma H, Awaya Y, Shiomi M, et al. Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis. Acta Neurol Scand. 2010;121:251–6.

    CAS  PubMed  Google Scholar 

  79. Claassen J, Hirsch LJ, Emerson RG, et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146–53.

    CAS  PubMed  Google Scholar 

  80. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62:1698–702.

    PubMed  Google Scholar 

  81. Schmutzhard E, Pfausler B. Complications of the management of status epilepticus in the intensive care unit. Epilepsia. 2011;52 Suppl 8:39–41.

    CAS  PubMed  Google Scholar 

  82. Holmes GL, Riviello Jr JJ. Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol. 1999;20:259–64.

    CAS  PubMed  Google Scholar 

  83. Kofke WA, Snider MT, Young RS, et al. Prolonged low flow isoflurane anesthesia for status epilepticus. Anesthesiology. 1989;71:653–9.

    CAS  PubMed  Google Scholar 

  84. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004;61:1254–9.

    PubMed  Google Scholar 

  85. Fugate JE, Burns JD, Wijdicks EFM, et al. Prolonged high-dose isoflurane for refractory status epilepticus: is it safe? Anesth Analg. 2010;111:1520–4.

    CAS  PubMed  Google Scholar 

  86. Arnold JH, Truog RD, Rice SA. Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesth Analg. 1993;76:520–6.

    CAS  PubMed  Google Scholar 

  87. Kelsall AW, Ross-Russell R, Herrick MJ. Reversible neurologic dysfunction following isoflurane sedation in pediatric intensive care. Crit Care Med. 1994;22:1032–4.

    CAS  PubMed  Google Scholar 

  88. McBeth C, Watkins TG. Isoflurane for sedation in a case of congenital myasthenia gravis. Br J Anaesth. 1996;77:672–4.

    CAS  PubMed  Google Scholar 

  89. Hughes J, Leach HJ, Choonara I. Hallucinations on withdrawal of isoflurane used as sedation. Acta Paediatr. 1993;82:885–6.

    CAS  PubMed  Google Scholar 

  90. Shankar V, Churchwell KB, Deshpande JK. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med. 2006;32:927–33.

    CAS  PubMed  Google Scholar 

  91. Riviello JJ, Ashwal S, Hirtz D, et al. Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review). Neurology. 2006;67:1542–50.

    PubMed  Google Scholar 

  92. Watemberg N, Segal G. A suggested approach to the etiologic evaluation of status epilepticus in children: what to seek after the usual causes have been ruled out. J Child Neurol. 2010;25:203–11.

    PubMed  Google Scholar 

  93. Cellucci T, Benseler SM. Diagnosing central nervous system vasculitis in children. Curr Opin Pediatr. 2010;22:731–8.

    PubMed  Google Scholar 

  94. Elbers J, Halliday W, Hawkins C, et al. Brain biopsy in children with primary small-vessel central nervous system vasculitis. Ann Neurol. 2010;68:602–10.

    PubMed  Google Scholar 

  95. Moritani T, Smoker WRK, Leee HK, et al. Differential diagnosis of cerebral hemispheric pathology. Clin Neuroradiol. 2011;21:53–63.

    CAS  PubMed  Google Scholar 

  96. Chassoux F, Landre E, Mellerio C, et al. Type II focal cortical dysplasia: electroclinical phenotype and surgical outcome related to imaging. Epilepsia. 2012;53:349–58.

    PubMed  Google Scholar 

  97. Aronica E, Becker AJ, Spreafico R. Malformations of cortical development. Brain Pathol. 2012;22:380–401.

    PubMed  Google Scholar 

  98. Loscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci. 2005;6:591–602.

    PubMed  Google Scholar 

  99. Kuteykin-Teplyakov K, Brandt C, Hoffmann K, et al. Complex time-dependent alterations in the brain expression of different drug efflux transporter genes after status epilepticus. Epilepsia. 2009;50:887–97.

    PubMed  Google Scholar 

  100. Bankstahl JP, Bankstahl M, Kuntner C, et al. A novel emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood brain barrier. J Neurosci. 2011;31:8803–11.

    CAS  PubMed Central  PubMed  Google Scholar 

  101. Iannetti P, Spalice A, Parisi P. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia. 2005;46:967–9.

    PubMed  Google Scholar 

  102. Schmitt FC, Dehnicke C, Merschhemke M, et al. Verapamil attenuates the malignant treatment course in recurrent status epilepticus. Epilepsy Behav. 2010;17:565–8.

    PubMed  Google Scholar 

  103. Mirski M, Williams M, Hanley DF. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit Care Med. 1995;23:400–4.

    CAS  PubMed  Google Scholar 

  104. Greiner HM, Tillema J-M, Hallinan BE, et al. Corpus callosotomy for treatment of pediatric refractory status epilepticus. Seizure. 2012;21:307–9.

    PubMed Central  PubMed  Google Scholar 

  105. Wheless JW. Treatment of refractory convulsive status epilepticus in children: other therapies. Semin Pediatr Neurol. 2010;17:190–4.

    PubMed  Google Scholar 

  106. Rosati A, L’Erario M, Ilvento L, et al. Efficacy and safety of ketamine in refractory status epilepticus in children. Neurology. 2012;79:2355–8.

    CAS  PubMed  Google Scholar 

  107. Gaspard N, Foreman B, Judd LM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54(8):1498–503.

    CAS  PubMed  Google Scholar 

  108. Orlowski JP, Erenberg G, Lueders H, Cruse RP. Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med. 1984;12:367–72.

    CAS  PubMed  Google Scholar 

  109. Elting JW, Naalt J, Fock JM. Mild hypothermia for refractory focal status epilepticus in an infant with hemimegalencephaly. Eur J Paediatr Neurol. 2010;14:452–5.

    PubMed  Google Scholar 

  110. Shein SL, Reynolds TQ, Gedela S, Kochanek PM, Bell MJ. Therapeutic hypothermia for refractory status epilepticus in a child with malignant migrating partial seizures of infancy and SCN1A mutation: a case report. Ther Hypothermia Temp Manag. 2012;2:144–9.

    PubMed Central  PubMed  Google Scholar 

  111. Nakagawa T, Fujita K, Saji Y, et al. Induced hypothermia/normothermia with general anesthesia prevents neurological damage in children with febrile refractory status epilepticus. No To Hattatsu. 2011;43:459–63.

    PubMed  Google Scholar 

  112. Villeneuve N, Pinton F, Bahi-Buisson N, et al. The ketogenic diet improves recently worsened focal epilepsy. Dev Med Child Neurol. 2009;51:276–81.

    PubMed  Google Scholar 

  113. Kumada T, Miyajima T, Kimura N, et al. Modified Atkins diet for the treatment of nonconvulsive status epilepticus in children. J Child Neurol. 2010;25:485–9.

    PubMed  Google Scholar 

  114. Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia. 2010;51:2033–7.

    PubMed  Google Scholar 

  115. Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia. 2011;52:1956–65.

    PubMed  Google Scholar 

  116. Nam SH, Lee BL, Lee CG, et al. The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia. 2011;52:e181–4.

    CAS  PubMed  Google Scholar 

  117. Vaccarezza M, Silva W, Maxit C, Agosta G. Super-refractory status epilepticus: treatment with ketogenic diet in pediatrics. Rev Neurol. 2012;55:20–5.

    PubMed  Google Scholar 

  118. Caraballo RH, Reyes G, Avaria MF, et al. Febrile infection-related epilepsy syndrome: a study of 12 patients. Seizure. 2013;22(7):553–9.

    PubMed  Google Scholar 

  119. Sort R, Born AP, Pedersen KN, Fonsmark L, Uldall P. Ketogenic diet in 3 cases of childhood refractory status epilepticus. Eur J Neurol. 2013. doi:10.1016/j.ejpn.2013.05.001, (ePub ahead of print).

    Google Scholar 

  120. da Jung E, Kang HC, Lee JS, et al. Safety and role of ketogenic parenteral nutrition for intractable childhood epilepsy. Brain Dev. 2012;34:620–4.

    Google Scholar 

  121. Strzelczyk A, Reif PS, Bauer S, et al. Intravenous initiation and maintenance of ketogenic diet: proof of concept in super-refractory status epilepticus. Seizure. 2013;22(7):581–3.

    PubMed  Google Scholar 

  122. Abend NS, Dlugos DJ, Hahn CD, et al. Use of EEG monitoring and management of non-convulsive seizures in critically ill patients: a survey of neurologists. Neurocrit Care. 2010;12:382–9.

    PubMed Central  PubMed  Google Scholar 

  123. Topjian AA, Gutierrez-Colina AM, Sanchez SM, et al. Electrographic status epilepticus is associated with mortality and worse short-term outcome in critically ill children. Crit Care Med. 2013;41:215–23.

    PubMed  Google Scholar 

  124. Hosain SA, Solomon GE, Kobylarz EJ. Electroencephalographic patterns in unresponsive pediatric patients. Pediatr Neurol. 2005;32:162–5.

    PubMed  Google Scholar 

  125. Jette N, Claassen J, Emerson RG, et al. Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children. Arch Neurol. 2006;63:1750–5.

    PubMed  Google Scholar 

  126. Saengpattrachai M, Sharma R, Hunjan A, et al. Nonconvulsive seizures in the pediatric intensive care unit: etiology, EEG, and brain imaging findings. Epilepsia. 2006;47:1510–8.

    PubMed  Google Scholar 

  127. Hyllienmark L, Amark P. Continuous EEG monitoring in a paediatric intensive care unit. Eur J Paediatr Neurol. 2007;11:70–5.

    PubMed  Google Scholar 

  128. Carrera E, Claassen J, Oddo M, et al. Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections. Arch Neurol. 2008;65:1612–8.

    PubMed  Google Scholar 

  129. Shahwan A, Bailey C, Shekerdemian L, et al. The prevalence of seizures in comatose children in the pediatric intensive care unit: a prospective video-EEG study. Epilepsia. 2010;51:1198–204.

    PubMed  Google Scholar 

  130. Abend NS, Gutierrez-Colina AM, Topjian AA, et al. Nonconvulsive seizures are common in critically ill children. Neurology. 2011;76:1071–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  131. McCoy B, Sharma R, Ochi A, et al. Predictors of nonconvulsive seizures among critically ill children. Epilepsia. 2011;52:1973–8.

    PubMed  Google Scholar 

  132. Greiner HM, Holland K, Leach JL, et al. Nonconvulsive status epilepticus: the encephalopathic pediatric patient. Pediatrics. 2012;129:e748–55.

    PubMed  Google Scholar 

  133. Kirkham FJ, Wade AM, McElduff F, et al. Seizures in 204 comatose children: incidence and outcome. Intensive Care Med. 2012;38:853–62.

    PubMed Central  PubMed  Google Scholar 

  134. Schreiber JM, Zelleke T, Gaillard WD, et al. Continuous video EEG for patients with acute encephalopathy in a pediatric intensive care unit. Neurocrit Care. 2012;17:31–8.

    PubMed  Google Scholar 

  135. Abend NS, Arndt DH, Carpenter JL, et al. Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality. Neurology. 2013;81:1–9.

    Google Scholar 

  136. Walker M, Cross H, Smith S, et al. Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. Epileptic Disord. 2005;7:253–96.

    PubMed  Google Scholar 

  137. Abend NS, Sanchez SM, Berg RA, Dlugos DJ, Topjian AA. Treatment of electrographic seizures and status epilepticus in critically ill children: a single center experience. Seizure. 2013;22:467–71.

    PubMed  Google Scholar 

  138. Sanchez SM, Carpenter J, Chapman KE, et al. Pediatric ICU EEG monitoring: current resources and practice in the United States and Canada. J Clin Neurophysiol. 2013;30:156–60.

    PubMed Central  PubMed  Google Scholar 

  139. Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): does duration of anesthesia affect outcome? Epilepsia. 2011;52 Suppl 8:28–30.

    PubMed  Google Scholar 

  140. Howell KB, Katanyuwong K, Mackay MT, et al. Long-term follow-up febrile infection-related epilepsy syndrome. Epilepsia. 2012;53:101–10.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Neurology and Anaesthesia (Pediatrics), Boston Children’s Hospital, 300 Longwood Avenue, Bader 627, Boston, MA, 02115, USA

    Robert C. Tasker MBBS, MD, FRCP

  2. Department of Cardiology, Children’s Hospitals of Atlanta, Atlanta, GA, USA

    Ryan Wilkes MD

Authors
  1. Robert C. Tasker MBBS, MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryan Wilkes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert C. Tasker MBBS, MD, FRCP .

Editor information

Editors and Affiliations

  1. Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

    Derek S. Wheeler

  2. Div. of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

    Hector R. Wong

  3. Pediatric Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA

    Thomas P. Shanley

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Tasker, R.C., Wilkes, R. (2014). Status Epilepticus. In: Wheeler, D., Wong, H., Shanley, T. (eds) Pediatric Critical Care Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-6356-5_41

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6356-5_41

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6355-8

  • Online ISBN: 978-1-4471-6356-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation